|
|
Volumn 23, Issue 30, 2005, Pages 7395-7396
|
|
Is there a role for routine p53 testing in colorectal cancer?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUOROURACIL;
FOLINIC ACID;
OXALIPLATIN;
PROTEIN P53;
ANTINEOPLASTIC AGENT;
ADVANCED CANCER;
CANCER CHEMOTHERAPY;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
COLORECTAL CANCER;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
GENE FUNCTION;
GENE LOCATION;
GENE MUTATION;
HIGH RISK PATIENT;
HUMAN;
IMMUNOHISTOCHEMISTRY;
OUTCOME ASSESSMENT;
PATIENT SELECTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN EXPRESSION;
TREATMENT PLANNING;
COLORECTAL TUMOR;
GENETIC PREDISPOSITION;
GENETICS;
MUTATION;
NOTE;
NUCLEOTIDE SEQUENCE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COLORECTAL NEOPLASMS;
DNA MUTATIONAL ANALYSIS;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
MUTATION;
TUMOR SUPPRESSOR PROTEIN P53;
|
|
EID: 32944480626
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2005.07.021 Document Type: Editorial |
|
Times cited : (13)
|
|
References (6)
|
